GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Capital DGMC Inc (TSXV:FGF.H) » Definitions » Research & Development

Capital DGMC (TSXV:FGF.H) Research & Development : C$0.00 Mil (TTM As of Jun. 2017)


View and export this data going back to 2010. Start your Free Trial

What is Capital DGMC Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Capital DGMC's Research & Development for the three months ended in Jun. 2017 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2017 was C$0.00 Mil.


Capital DGMC Research & Development Historical Data

The historical data trend for Capital DGMC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Capital DGMC Research & Development Chart

Capital DGMC Annual Data
Trend Dec05 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Capital DGMC Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Capital DGMC Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Capital DGMC  (TSXV:FGF.H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Capital DGMC Research & Development Related Terms

Thank you for viewing the detailed overview of Capital DGMC's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Capital DGMC (TSXV:FGF.H) Business Description

Traded in Other Exchanges
N/A
Address
c/o M. Daniel Dumont, 1155, boul. Rene-Levesque O., Bureau 2660, Montreal, QC, CAN, H3B 4S5
Capital DGMC Inc offers orthopedic devices, such as custom foot orthotics, knee orthoses, and orthopedic shoes in Canada.

Capital DGMC (TSXV:FGF.H) Headlines

No Headlines